Bio-Techne Announces Opening of New Canadian Facility

MINNEAPOLIS, Oct. 1, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace for approximately 40 Bio-Techne employees and reflects the Company’s commitment to supporting the Canadian life sciences industry as well as expectations for continued growth in this geography. The... Read more

MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more

10x Genomics Becomes a Partner in the CanSeq150 Initiative

–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—April 5, 2018—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes... Read more

SIGNA Premier Licensed by Health Canada

Toronto, Canada – March 20, 2018 – GE Healthcare is proud to announce SIGNA™ Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in Canada. SIGNA Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design... Read more